Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 GI Protection: Restoring Gut Integrity & Function

The landscape of biological research is always shifting, isn't it? In 2026, we're witnessing a truly significant, sometimes dramatic, shift in how we approach gastrointestinal health and recovery. For far too long, GI issues have plagued countless individuals,

The landscape of biological research is always shifting, isn't it? In 2026, we're witnessing a truly significant, sometimes dramatic, shift in how we approach gastrointestinal health and recovery. For far too long, GI issues have plagued countless individuals, often leaving them in a cycle of discomfort and compromised well-being. From occasional indigestion to more persistent, debilitating conditions, the gut's intricate ecosystem is astonishingly delicate, yet incredibly vital for overall physiological function. That's where the compelling research surrounding BPC-157 GI protection really captures our attention.

Here at Real Peptides, our team has been tracking the peptide research space with unflinching dedication for years. We've seen firsthand the burgeoning interest in compounds that don't just mask symptoms but genuinely support the body's innate healing capacities. BPC-157, a fascinating investigational peptide, stands out in this regard. Its potential for comprehensive gastrointestinal protection isn't just a talking point; it's a focus of intensive study, and for good reason. We're talking about a compound that could truly redefine how we understand and support the gut's incredible resilience. Our collective expertise tells us this is a critical area for researchers to explore, and we're committed to providing the high-purity materials needed to advance these vital studies.

The Formidable Challenges Facing Modern GI Health

Let's be honest, modern life isn't always kind to our digestive systems. Between demanding schedules, high expectations, and environmental stressors, our guts are under constant siege. The sheer prevalence of gastrointestinal complaints in 2026 is staggering, isn't it? We're seeing an increasing number of researchers focusing on conditions like inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), gastritis, and various forms of mucosal damage. These aren't just minor inconveniences; they represent chronic, often debilitating, challenges that significantly diminish quality of life. Traditional approaches often fall short, offering symptomatic relief but rarely addressing the root causes of tissue damage or impaired healing.

This isn't just about diet anymore, though nutrition plays a critical, non-negotiable element. It's about understanding the complex interplay of genetics, environment, microbial balance, and cellular signaling within the gut. When the delicate balance of the GI tract is disrupted, whether by stress, medication, pathogens, or dietary insults, the consequences can be cascading. This creates an urgent need for novel compounds capable of fostering genuine healing and robust BPC-157 GI protection. Our experience shows that researchers are actively seeking compounds that can go beyond palliation, aiming instead for restorative mechanisms. This pursuit aligns perfectly with our mission at Real Peptides: to empower cutting-edge biological research with unparalleled purity and consistency.

Unpacking BPC-157: A Peptide with Profound Regenerative Potential

So, what exactly is BPC-157? It's a synthetically produced peptide, a partial sequence of human Body Protection Compound (BPC) found naturally in gastric juice. But don't let its humble origins fool you; its therapeutic potential, particularly regarding BPC-157 GI protection, is anything but humble. Research suggests it possesses a remarkable array of regenerative and cytoprotective properties. Scientists have been investigating its role in wound healing across various tissues, from tendons and ligaments to muscles and, critically, the gastrointestinal tract.

What makes BPC-157 so compelling for gut health research? It's its unique pleiotropic actions. We're not talking about a single-target drug; we're talking about a multifaceted signaling molecule that appears to orchestrate a symphony of healing responses. Our team has observed the growing body of literature highlighting its ability to accelerate healing in damaged tissues, reduce inflammation, and even improve blood flow. These aren't isolated effects; they converge to create a powerful strategy for BPC-157 GI protection. When researchers procure high-purity BPC-157 10mg or convenient BPC-157 Tablets from Real Peptides, they're investing in the foundational quality necessary for robust, reproducible experimental outcomes. That's the reality. It all comes down to reliable materials.

The Intricate Science Behind BPC-157 GI Protection: Unraveling the Mechanisms

The mechanisms by which BPC-157 exerts its protective and regenerative effects on the GI tract are quite complex, reflecting its broad biological activity. We believe understanding these pathways is absolutely crucial for any researcher delving into BPC-157 GI protection. It's not magic; it's sophisticated molecular biology. Here's what we've learned through our continuous engagement with the scientific community and our commitment to understanding the compounds we supply:

Promoting Angiogenesis and Tissue Regeneration

One of the most well-documented actions of BPC-157 is its capacity to promote angiogenesis – the formation of new blood vessels. Why is this so important for the gut? A robust blood supply is paramount for delivering oxygen and nutrients to damaged tissues, facilitating waste removal, and ultimately accelerating the healing process. In conditions like gastric ulcers or inflammatory lesions, compromised blood flow can significantly impede recovery. BPC-157 appears to upregulate growth factors like Vascular Endothelial Growth Factor (VEGF), which are central to this process. This enhanced vascularity means faster, more efficient tissue repair, directly contributing to superior BPC-157 GI protection.

Potent Anti-inflammatory Effects

Inflammation is a double-edged sword. While essential for initiating healing, chronic or uncontrolled inflammation wreaks havoc on the delicate GI lining. BPC-157 has shown remarkable anti-inflammatory properties, modulating various inflammatory mediators. It appears to counteract the damaging effects of pro-inflammatory cytokines, reducing oxidative stress, which is a key contributor to tissue damage in many GI conditions. By dampening the inflammatory cascade, BPC-157 helps to create a more conducive environment for healing, preventing further injury and reinforcing BPC-157 GI protection effectively. It's a critical aspect of its comprehensive profile.

Strengthening the Gut Barrier: Collagen Synthesis and Tight Junction Integrity

The gut barrier, a single layer of epithelial cells, is our first line of defense against harmful substances. When this barrier is compromised – often referred to as 'leaky gut' – it can lead to a host of systemic issues. BPC-157 appears to play a role in strengthening this barrier. Research suggests it promotes collagen synthesis, which is vital for the structural integrity of the gut wall. Moreover, it may help maintain or restore the integrity of tight junctions, the specialized structures that seal the spaces between epithelial cells. This particular facet of BPC-157 GI protection is incredibly exciting for those studying permeability issues and their broader health implications. Ensuring optimal gut barrier function is paramount.

Modulating Growth Factors and Signaling Pathways

Beyond VEGF, BPC-157 influences a variety of other growth factors and signaling pathways essential for tissue repair and maintenance. It interacts with the nitric oxide (NO) system, which plays a crucial role in vasodilation and mucosal defense. It also appears to protect cells from various stressors, enhancing their survival and function. This broad-spectrum modulation underscores why BPC-157 is considered a 'stable gastric pentadecapeptide,' acting as a master regulator of tissue homeostasis and recovery within the GI system. Our commitment to supporting Gut Health Research means we're constantly evaluating new findings in this dynamic field.

Research Applications and Our Professional Observations

The sheer breadth of research applications for BPC-157 in GI health is truly impressive. We've seen studies exploring its efficacy in models of gastric ulcers induced by various means (NSAIDs, alcohol, stress), inflammatory bowel conditions (like colitis), and esophageal damage. In these scenarios, BPC-157 consistently demonstrates its capacity to accelerate healing, reduce lesion size, and restore mucosal integrity. This isn't just theoretical; the evidence for BPC-157 GI protection is becoming increasingly robust in preclinical models.

Our team has observed that a significant challenge in this research space lies in the variability of peptide quality. That's why Real Peptides makes it our absolute priority to deliver products crafted through small-batch synthesis with exact amino-acid sequencing, guaranteeing purity, consistency, and lab reliability. When you're dealing with delicate biological systems, the integrity of your research compounds is paramount. We can't stress this enough. Imperfect peptides can lead to unreliable data, wasting precious research time and resources. For comprehensive protocols, researchers often consider other powerful compounds like KPV for its anti-inflammatory properties or Thymosin Alpha 1 for immune support, recognizing the multifaceted nature of healing. Our Healing & Total Recovery Bundle is specifically curated with these broad applications in mind.

Navigating BPC-157 Research: Purity and Protocols

Conducting meaningful research with BPC-157 requires more than just enthusiasm; it demands meticulous attention to detail, especially concerning peptide purity and experimental protocols. We mean this sincerely: the quality of your research materials directly correlates with the validity of your findings. Unlike many providers in the space, Real Peptides focuses relentlessly on precision. Every peptide, including our BPC-157 variants, undergoes rigorous quality control to ensure it meets the highest standards for research. This commitment is why we've become a trusted name for serious biological research.

When working with compounds like BPC-157, proper handling and reconstitution are also critical. We recommend using high-quality Bacteriostatic Reconstitution Water (bac) to maintain the integrity and sterility of the peptide solution. This isn't just a suggestion; it's a fundamental step in ensuring your experiments are set up for success. Ignoring these seemingly minor details can compromise your entire study, distorting any observations related to BPC-157 GI protection. Our team is always available to answer questions regarding best practices for peptide handling, ensuring researchers are equipped with not just premium materials, but also the knowledge to use them effectively.

The Broader Picture: BPC-157 in a Holistic Research Framework

While we're intensely focused on BPC-157 GI protection, it's important to view this peptide's potential within a broader, more holistic research framework. The gut doesn't operate in isolation; it's intimately connected to the immune system, the nervous system, and metabolic health. Consequently, improvements in GI integrity and function can have far-reaching positive implications for overall physiological well-being. Researchers exploring the gut-brain axis, for example, are finding BPC-157's effects on the enteric nervous system to be particularly intriguing, adding another layer to its comprehensive benefits.

We often find that researchers combine BPC-157 with other peptides to explore synergistic effects. For instance, pairing it with compounds known for systemic healing or anti-inflammatory actions can create a more powerful research protocol. This multi-pronged approach, which we've refined over years of observation, delivers real results in preclinical settings. The pursuit of optimal health and recovery is rarely a single-bullet solution; it's a tapestry of interconnected biological processes. Our full peptide collection offers a wide array of high-purity compounds for researchers designing these complex, nuanced studies. We're here to help you Find the Right Peptide Tools for Your Lab.

Comparative Approaches to GI Support in Research

When considering BPC-157 GI protection, it's helpful to understand how its mechanisms compare to other research approaches for supporting gastrointestinal health. This table outlines some key differences and why BPC-157 presents a unique avenue for investigation.

Primary Mechanism

Direct tissue regeneration, angiogenesis, anti-inflammatory, cytoprotective, tight junction stabilization, growth factor modulation.

Modulating gut microbiota, producing beneficial metabolites, enhancing barrier function indirectly, immune system modulation.

Suppressing inflammatory pathways (e.g., COX inhibition) to reduce pain and swelling.

Focus of Action

Directly on damaged epithelial cells, vascular system, and inflammatory cascades within the gut lining.

Primarily on the microbial ecosystem; indirect effects on host physiology through microbial interactions.

Systemic or localized inflammation; does not directly promote tissue regeneration or angiogenesis.

Repair & Regeneration

High potential for direct tissue repair, accelerating wound healing, and restoring structural integrity.

Indirectly supports epithelial health through microbial balance; limited direct regenerative capacity.

Minimal direct regenerative properties; primarily focused on symptom management and inflammation reduction.

Versatility

Broad applicability across various types of GI damage (ulcers, inflammation, leaky gut models).

Strain-specific effects; efficacy varies greatly depending on the type of probiotic and specific GI condition being studied.

Targeted for inflammation; may have side effects on GI mucosa with prolonged use, potentially exacerbating some issues.

Research Appeal in 2026

Cutting-edge, high interest for regenerative medicine and complex GI pathologies.

Established but continually evolving; focus on strain specificity and precision microbiome engineering.

Well-understood, but often associated with side effects, driving research into alternatives.

This comparison highlights BPC-157's distinctive role as a powerful research tool focused on fundamental regenerative processes, offering a compelling alternative to more symptomatic or indirect approaches. The direct impact of BPC-157 GI protection on tissue healing is what truly sets it apart.

Our Unwavering Commitment to Research Excellence

At Real Peptides, our ethos is built on the pillars of purity, precision, and unwavering support for the scientific community. We understand the grueling road warrior hustle of research, the painstaking efforts involved in every experiment. That's why we meticulously craft every peptide through small-batch synthesis with exact amino-acid sequencing. Our dedication to quality means researchers can confidently explore the profound potential of compounds like BPC-157, knowing they're working with the most reliable materials available. We stand behind every product we sell, ensuring you have a trusted partner in your research endeavors.

Our commitment extends beyond just providing high-purity peptides. It's about fostering an environment where breakthrough discoveries can flourish. We recognize that the future of medicine, the future of health, hinges on the rigorous, ethical research being conducted today. That's why we invite you to Explore High-Purity Research Peptides on our website. We believe that by providing the highest quality tools, we're not just selling products; we're actively contributing to advancements that will shape the health landscape for generations to come. This focus on foundational quality is crucial for understanding the full scope of BPC-157 GI protection and countless other peptide applications.

Looking Ahead: The Future of BPC-157 GI Protection

The story of BPC-157 GI protection is far from fully written. As we move further into 2026, research continues to unfold, revealing even more nuanced aspects of this remarkable peptide. We anticipate a surge in studies exploring its long-term effects, optimal research protocols, and potential synergies with other novel compounds. The ongoing quest to understand and harness the body's natural healing capabilities is one of the most exciting frontiers in biotechnology, and BPC-157 is undeniably at its forefront.

For researchers, staying abreast of these developments is key. We encourage continuous learning and collaboration, because collective knowledge is truly how we push the boundaries of what's possible. The insights gained from dedicated research into BPC-157 GI protection today will undoubtedly pave the way for a healthier future tomorrow. We're proud to be a part of that journey, providing the foundational quality that enables groundbreaking discoveries. Our mission is to support your vital work, helping you to Discover Premium Peptides for Research that deliver consistent, reliable results.

Frequently Asked Questions

BPC-157 is a synthetic peptide, a partial sequence of a naturally occurring human gastric juice protein. In research, it’s being studied for its profound regenerative properties, particularly its ability to foster healing and integrity within the gastrointestinal tract, contributing significantly to BPC-157 GI protection.

BPC-157’s mechanisms include promoting angiogenesis (new blood vessel formation), modulating inflammatory responses, and enhancing collagen synthesis, all of which are critical for repairing damaged mucosal lining and strengthening the gut barrier. These actions underpin its role in BPC-157 GI protection.

Researchers are investigating BPC-157’s effects in preclinical models of various GI issues, including gastric ulcers, inflammatory bowel conditions (like colitis), and damage to the esophageal lining. The goal is to understand how BPC-157 GI protection can address a wide spectrum of digestive challenges.

High peptide purity is absolutely essential for reliable and reproducible research outcomes. Impure peptides can introduce confounding variables, leading to inaccurate data and wasted resources. At Real Peptides, we ensure our BPC-157 is of the highest research-grade quality to support precise studies into BPC-157 GI protection.

Yes, many researchers explore synergistic effects by combining BPC-157 with other peptides known for their anti-inflammatory or regenerative properties, such as KPV or Thymosin Alpha 1. This multi-pronged approach aims to enhance comprehensive BPC-157 GI protection and overall recovery.

BPC-157 appears to strengthen the gut barrier by promoting collagen synthesis and helping to maintain the integrity of tight junctions between epithelial cells. This is crucial for preventing ‘leaky gut’ and contributing to robust BPC-157 GI protection against harmful substances.

Research suggests BPC-157 modulates various inflammatory mediators and reduces oxidative stress within the gut. By dampening the inflammatory cascade, it helps create a more favorable environment for healing, which is a key component of its BPC-157 GI protection capabilities.

Unlike traditional approaches that often focus on symptomatic relief, BPC-157 is being researched for its direct regenerative actions, promoting tissue repair and angiogenesis. This fundamental healing potential makes BPC-157 GI protection a unique area of study compared to indirect or palliative methods.

For reliable research into BPC-157 GI protection, it’s critical to source peptides from reputable suppliers. Real Peptides specializes in high-purity, research-grade peptides, ensuring exact amino-acid sequencing and consistency for your laboratory’s needs. You can explore our BPC-157 offerings on our website.

Proper handling includes using sterile techniques for reconstitution and storage. We recommend using high-quality Bacteriostatic Reconstitution Water to maintain the peptide’s integrity and sterility. Following these best practices is vital for accurate research results concerning BPC-157 GI protection.

Absolutely. BPC-157’s ability to promote angiogenesis ensures that damaged GI tissues receive an adequate supply of oxygen and nutrients. This enhanced blood flow is fundamental for accelerating the healing process and is a core mechanism behind BPC-157 GI protection.

We employ small-batch synthesis and rigorous quality control measures, including exact amino-acid sequencing, for every peptide we supply. This meticulous process guarantees the purity and consistency that researchers need for reliable studies on BPC-157 GI protection and other compounds.

Cytoprotective means that BPC-157 helps protect cells from damage and stress. In the GI tract, this involves safeguarding the delicate epithelial cells from various insults, enhancing their survival and function, which is a key aspect of comprehensive BPC-157 GI protection.

Yes, our ‘Healing & Total Recovery Bundle’ is designed to support comprehensive regenerative research, often including compounds like BPC-157. This bundle is curated to offer synergistic peptides for broad-spectrum healing and BPC-157 GI protection studies. You can explore it on our website.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosing Protocols from Preclinical and Case Literature

BPC-157 studied plantar fasciitis case reports document subcutaneous injection protocols ranging from 250–500 mcg daily, administered either systemically (abdominal subcutaneous tissue) or locally (periwound injection near the plantar fascia insertion). Animal models used 10 mcg/kg daily, which extrapolates to approximately 700 mcg for a 70 kg human using direct mg/kg conversion. Though allometric scaling (which accounts for metabolic rate differences between species) suggests 200–350 mcg may be the functional human equivalent dose. Local injection near the injury site versus systemic administration remains debated. A 2017 study in the Journal of Physiology and Pharmacology found that systemic BPC-157 administration (intraperitoneal injection in rats) produced tendon healing effects comparable to local injection, suggesting the peptide circulates systemically and concentrates at injury sites through chemotactic signaling. Human practitioners report both approaches. Some inject directly into the heel fat pad adjacent to the plantar fascia origin, others use abdominal subcutaneous injections and rely on systemic distribution. Injection frequency follows daily or twice-daily schedules in documented protocols. BPC-157 has an estimated half-life of 4–6 hours based on peptide stability studies, meaning plasma concentrations drop significantly between doses. Twice-daily dosing (morning and evening) maintains more consistent tissue exposure, though whether this translates to better …
STORAGE

Storage and Reconstitution Requirements for Joint Research Protocols

BPC-157 is supplied as lyophilized powder and must be stored at −20°C before reconstitution. Once mixed with bacteriostatic water, the solution remains stable at 2–8°C (standard refrigeration) for up to 28 days, though some research groups use it within 14 days to minimize degradation. Temperature excursions above 8°C denature the peptide irreversibly. A single overnight incident at room temperature renders the vial unusable, even if it appears visually unchanged. Unlike larger proteins, BPC-157's 15-amino-acid chain is vulnerable to oxidation; antioxidant-free bacteriostatic water (0.9% benzyl alcohol in sterile water) is the standard reconstitution vehicle. Cartalax stability depends on formulation. Oral capsules can be stored at room temperature (15–25°C) in a sealed container away from moisture. Injectable Cartalax follows the same lyophilized storage rules as BPC-157: −20°C before reconstitution, 2–8°C after mixing, use within 28 days. Because Cartalax is a tetrapeptide (even shorter than BPC-157), it's more susceptible to hydrolysis. Some researchers prepare single-use vials rather than multi-dose vials to avoid repeated punctures that introduce air and potential contaminants. Reconstitution errors are the most common failure point in peptide research. Inject bacteriostatic water slowly down the side of the vial. Never directly onto the powder. To prevent foaming and peptide aggregation. Swirl gently; do not shake. Let the vial sit for 60–90 seconds to fully dissolve b…
02

Question drills

Open a question for its connected answer.

01What If I'm Taking NSAIDs for Pain — Can I Use BPC-157 Simultaneously?+

Yes, and research suggests BPC-157 may counteract NSAIDs' negative effects on healing. A 2013 study published in the Journal of Physiology and Pharmacology demonstrated that BPC-157 restored tendon healing velocity in rats treated with diclofenac. An NSAID known to impair collagen synthesis. The peptide appears to bypass COX inhibition and maintain healing progression through alternative pathways involving nitric oxide modulation. However, this doesn't mean NSAIDs are harmless. If pain management allows, minimising NSAID use during tissue repair remains the evidence-based recommendation.

SOURCE / realpeptides.co ↗
02What If I Have a Meniscal Tear and Want to Try BPC-157?+

Consult an orthopedic surgeon first. Meniscal tears vary widely in location, size, and mechanism, and some require immediate surgical intervention to prevent joint locking or cartilage damage. BPC-157 is not legally available by prescription in the United States and sourcing it from research chemical suppliers carries quality risks (unknown purity, incorrect dosing, contamination). The peptide has never been tested in humans for safety or efficacy, so dosing protocols, injection sites, and adverse event profiles remain speculative extrapolations from animal studies.

SOURCE / realpeptides.co ↗
03What If Arthritis Is Advanced — Will BPC-157 Still Work?+

BPC-157 studied arthritis research shows the most dramatic effects in early-to-moderate disease stages where viable chondrocytes still exist. Once cartilage is completely eroded down to exposed subchondral bone (Kellgren-Lawrence Grade 4 osteoarthritis), there's limited substrate for regeneration. You can't rebuild tissue from cells that no longer exist. That said, even in advanced arthritis, BPC-157 may reduce synovial inflammation and improve joint mobility by acting on surrounding soft tissue. Don't expect regeneration of bone-on-bone joints, but symptomatic improvement is plausible based on the anti-inflammatory data.

SOURCE / realpeptides.co ↗
04What If I Accidentally Inject a Small Air Bubble Subcutaneously?+

Inject it and move on. The bubble will diffuse harmlessly into surrounding tissue. You might feel slight pressure at the injection site for 20–30 minutes, similar to the sensation after any subcutaneous injection, but there's no medical risk. The air volume in a typical BPC-157 syringe (0.01–0.05mL) is absorbed through passive diffusion across tissue membranes within 24 hours. Document the incident in your research log if dose precision matters for your protocol, but don't treat it as a safety event.

SOURCE / realpeptides.co ↗
05What If the Healing Timeline Extends Beyond the Expected 8–12 Weeks?+

Extended timelines are common in subjects over 60, particularly in avascular tissue (tendons, ligaments). If progress plateaus after 12 weeks at 200–250mcg, the issue is rarely peptide dose. It's mechanical loading. Controlled resistance exercise or eccentric loading is required to signal collagen remodelling. BPC-157 supports angiogenesis and cellular migration, but it doesn't replace the mechanical stimulus required for structural tissue organisation.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

BPC-157 Complete Research Guide: Mechanisms, Applications & Studies

Research Notice: This article covers research on KLOW Stack research peptide blend — available from Palmetto Peptides for laboratory use only. Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines. Research Disclaimer: BPC-157 is sold by Palmetto Peptides strictly as a research compound for in vitro and laboratory use only. It is not intended for human or veterinary consumption, administration, or therapeutic use. BPC-157 is one of the most extensively studied synthetic peptides in preclinical research. Researchers can order BPC-157 research peptide from Palmetto Peptides with full lot-specific COA documentation. For combined tissue repair research, the BPC-157 + TB-500 Wolverine Stack is also available. Last Updated: March 20, 2026 | Reading Time: Approximately 3 minutes | Author: Palmetto Peptides Research Team

RESEARCH

Is BPC-157 available for laboratory research?

Yes. BPC-157 is available as a research-grade peptide for licensed laboratory and in vitro use. Palmetto Peptides supplies COA-verified, third-party tested BPC-157 for research purposes only.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

BPC-157 Studied Rheumatoid Arthritis: Model Comparison

Adjuvant-Induced Arthritis (AIA) T-cell mediated, mimics human RA inflammatory cascade 10 mcg/kg IP daily Joint swelling, histological erosion score, cytokine levels 70% reduction…

Comparison

BPC-157 Studied Shin Splints: Comparison to Standard Treatment Protocols

Rest + Activity Modification Reduces mechanical stress; allows natural periosteal healing 4–8 weeks for symptom resolution High (supported by clinical guidelines) Doesn't accelera…